C8 MediSensors, a US-based diabetes treatment company backed by US-based conglomerate General Electric, has raised $19m. The funding will help C8 MediSensors launch in Europe. C8 MediSensors said its “leading investors” participated in the round. C8 MediSensors uses light, in a process called Raman spectroscopy, to allow diabetics to measure glucose in a monitor. C8…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
